Company: PFSA
Filing Date: 2025-04-03
Form Type: S-4/A
Source: 0001213900-25-028544
Chunk: 585

Company: Profusa, Inc.
Filing Date: 2025-04-03
Form: S-4/A
Chunk 585
---
 operating segment. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer, Ben Hwang, who reviews financial information presented on a consolidated net loss basis as reported on the consolidated statement of operations in order to make decisions about allocating resources and assessing performance for the entire Company. The CODM also utilizes the Company’s long -rangeplan, which includes product development roadmaps and long -rangefinancial models, as a key input to resource allocation. The CODM function approves of key operating and strategic decisions. The CODM function views the Company’s F-54

PROFUSA, INC. AND SUBSIDIARY
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS Note 14 — Segments (cont.) operations and manages its business on a consolidated basis and as a single reportable operating segment. The CODM function is regularly provided with the following significant segment expenses. Significant expenses include research and development and general and administrative expenses, which are each separately presented in the Company’s Consolidated Statements of Operations. The CODM reviews significant expenses within both the research and development and the general and administrative categories. Other segment items within net loss include interest income, interest expense and loss on change in fair value of related party loan. See the consolidated financial statements for other financial information regarding the Company’s operating segment.

|                                                                                                                                       |     | Year Ended   
 December 31, |   2024 |   |     |   |    2023 |   |
|:--------------------------------------------------------------------------------------------------------------------------------------|:----|:-------------|-------:|:--|:----|:--|--------:|:--|
| Government grant revenue                                                                                                              |     | $            |    100 |   |     | $ |      45 |   |
| Operating expenses:                                                                                                                   |     |              |        |   |     |   |         |   |
| Research personnel compensation costs, including stock-based compensation                                                             |     |              |  1,350 |   |     |   |   1,641 |   |
| CRO and regulatory costs                                                                                                              |     |              |     36 |   |     |   |     186 |   |
| Administrative personnel compensation costs, including stock-based compensation                                                       |     |              |  1,592 |   |     |   |   1,434 |   |
| Rent and office costs                                                                                                                 |     |              |    279 |   |     |   |     365 |   |
|